ProPepMD
Semaglutide – 1-Month Supply – 503A Compounded
Semaglutide – 1-Month Supply – 503A Compounded
This product is available after consultation with a specialist.
An in-person consultation with a RELAX specialist is required to discuss this product. Availability depends on clinical suitability and any applicable prescription requirements.
1mg/mL
A glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.
Supplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at 1mg/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. One vial provides a 28-day supply.
2mg/mL
A glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.
Supplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at 2mg/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. One vial provides a 28-day supply.
4mg/mL
A glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.
Supplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at 4mg/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. One vial provides a 28-day supply.
6mg/mL
A glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.
Supplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at 6mg/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. One vial provides a 28-day supply.
10mg/mL
A glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.
Supplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at 10mg/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. One vial provides a 28-day supply.
Vial size listed by supplier 1 mL
Supplier availability · In stock
Share
